USMLE Prep - Medical Reference Library

Acute Bacterial Meningitis (Adults) — Empiric Therapy, Dexamethasone, and LP Strategy

System: Infectious Diseases • Reviewed: Sep 1, 2025 • Step 1Step 2Step 3

Synopsis:

Treat immediately: draw blood cultures, give dexamethasone and empiric antibiotics before/with first dose, and obtain CT only when indicated (focal deficit, immunocompromise, papilledema). Tailor regimen by age/risk (Listeria coverage if >50 or immunocompromised).

Key Points

  • Use the highest‑yield diagnostic test early; do not let testing delay time‑critical therapy.
  • Set objective targets (hemodynamic, neurologic, respiratory) and reassess frequently.
  • Plan definitive source control or reperfusion when indicated; document follow‑up and patient education.

Algorithm

  1. Suspect meningitis → obtain blood cultures immediately.
  2. Give dexamethasone, then start empiric antibiotics without delay.
  3. CT head only if focal neuro signs, new seizure, immunocompromise, or papilledema; otherwise proceed directly to LP.
  4. Perform LP; send CSF for Gram stain, culture, cell count, glucose, protein, PCR.
  5. Tailor antibiotics to organism/MIC; continue dexamethasone if pneumococcal confirmed.
  6. Implement droplet precautions when N. meningitidis suspected; give prophylaxis to close contacts.

Clinical Synopsis & Reasoning

Treat immediately: draw blood cultures, give dexamethasone and empiric antibiotics before/with first dose, and obtain CT only when indicated (focal deficit, immunocompromise, papilledema). Tailor regimen by age/risk (Listeria coverage if >50 or immunocompromised).


Treatment Strategy & Disposition

Stabilize ABCs. Initiate guideline‑concordant first‑line therapy with precise dosing and continuous monitoring. Escalate to advanced/procedural interventions based on explicit failure criteria. Define ICU, step‑down, and ward disposition triggers; involve specialty teams early.


Epidemiology / Risk Factors

  • Risk varies by comorbidity and precipitants; see citations for condition‑specific data.

Investigations

TestRole / RationaleTypical FindingsNotes
CT head (only with risk features)Safety screen for LPMass effect riskDo not delay antibiotics/dexamethasone
Lumbar punctureDefinitive CSFNeutrophilic pleocytosis, low glucose, high proteinSend Gram stain/culture/PCR
Blood culturesPathogen IDOften positiveDraw before antibiotics if possible

Pharmacology

Medication/InterventionMechanismOnsetRole in TherapyLimitations
Dexamethasone 10 mg IV q6h x4 daysGlucocorticoidHoursReduce neurologic sequelae (pneumococcal)Give before/with first antibiotic dose
Ceftriaxone 2 g IV q12h + VancomycinAntibioticsHoursEmpiric 18–50 yearsAdjust to MICs
Add Ampicillin 2 g IV q4hAntibioticHoursAdd if >50 or immunocompromised (Listeria)Dose by renal function

Prognosis / Complications

  • Outcome depends on timeliness of diagnosis and definitive therapy; monitor for complications.

Patient Education / Counseling

  • Provide red‑flag education, adherence guidance, and explicit return precautions; arrange timely specialty follow‑up.

References

  1. IDSA Practice Guideline: Bacterial Meningitis (Adults) — Link